7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Supraventricular Tachycardia
Supraventricular Tachycardia (SVT) is a cardiovascular condition marked by an excessively rapid heartbeat originating above the heart's ventricles. The underlying cause often involves abnormal electrical pathways within the heart, leading to rapid and irregular contractions. Individuals experiencing SVT may encounter fleeting or extended episodes, accompanied by symptoms such as palpitations, dizziness, and breathlessness. Though not typically life-threatening, SVT can substantially disrupt daily life and impact overall well-being. Addressing SVT may involve various approaches, from lifestyle adjustments and pharmaceutical interventions to more invasive procedures like catheter ablation, which aims to restore a normal heart rhythm. Accurate diagnosis and effective management are pivotal in alleviating symptoms and preventing potential complications associated with this prevalent cardiac arrhythmia.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya